SARomics Biostructures is a leading structural biology and drug discovery CRO based in Medicon Village, Lund, Sweden. It specializes in providing advanced structural biology and integrated drug discovery outsourcing services. The company was founded in 2006 by scientists with a mission to accelerate clients’ drug discovery projects by offering premium CRO services in structural biology and drug discovery. Starting with just one employee and a small crystallization room at the MAX II synchrotron, we developed a fully equipped platform with advanced technology to support structural biology and drug discovery. The platform includes protein cloning, expression, purification, biophysical characterization, crystallization, and structure determination using X-ray crystallography and NMR spectroscopy. Our fragment screening capabilities include proprietary fragment libraries, weak-affinity chromatography (WAC) technology, and NMR– and crystallographic fragment screening. Located at Medicon Village in Lund, near the 4th-generation MAX IV synchrotron, we provide priority access to the BioMAX and MicroMax beamlines, which are equipped for crystallographic fragment screening and serial crystallography experiments. Our FastLane library, which includes over 600 off-the-shelf drug target proteins for crystallization with our clients’ ligands and a turnaround time of just a few weeks, further accelerates clients’ drug discovery projects. Over the past twenty years, we have worked with the majority of the top ten pharmaceutical companies, many of the world’s most innovative biotech firms, and academic groups across a broad range of drug-target classes.
